Atrium Therapeutics
RNA
#4336
Rank
S$3.11 B
Marketcap
S$19.79
Share price
-6.47%
Change (1 day)
-49.67%
Change (1 year)

Atrium Therapeutics (RNA) - Total liabilities

Total liabilities on the balance sheet as of December 2025 : S$90.9 Million

According to Atrium Therapeutics's latest financial reports the company's total liabilities are S$90.9 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Atrium Therapeutics - Total liabilities on balance sheet (from 2024 to 2025)

Total liabilities by year

Year Total liabilities Change
2025-12-31S$91.24 M-1.71%
2024-12-31S$92.82 M-13.13%
2023-12-31S$0.10 B